Evidence map›Paper›PMID 30484125›Full record

ArticleJournal of industrial microbiology & biotechnology2019

Systematic investigation of CRISPR-Cas9 configurations for flexible and efficient genome editing in Corynebacterium glutamicum NRRL-B11474.

R Cameron Coates, Stephen Blaskowski, Shawn Szyjka, Harmen M van Rossum, Jim Vallandingham, Kedar Patel, Zach Serber, Jed Dean

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Synthetic biology tools for engineeringComputational and structural biotechnology journal · 2023
    Review
  3. Article
  4. Review
  5. Review
  6. Single-Base Genome Editing inJournal of microbiology and biotechnology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution.

R Cameron CoatesZymergen Inc., 5980 Horton St #105, Emeryville, CA, 94608, USA.
Stephen BlaskowskiZymergen Inc., 5980 Horton St #105, Emeryville, CA, 94608, USA.
Shawn SzyjkaZymergen Inc., 5980 Horton St #105, Emeryville, CA, 94608, USA.
Harmen M van RossumZymergen Inc., 5980 Horton St #105, Emeryville, CA, 94608, USA.
Jim VallandinghamZymergen Inc., 5980 Horton St #105, Emeryville, CA, 94608, USA.
Kedar PatelZymergen Inc., 5980 Horton St #105, Emeryville, CA, 94608, USA.
Zach SerberZymergen Inc., 5980 Horton St #105, Emeryville, CA, 94608, USA.
Jed DeanZymergen Inc., 5980 Horton St #105, Emeryville, CA, 94608, USA. jdean@zymergen.com.
Zymergen (United States)

Funding

Defense Advanced Research Projects Agency HR0011-15-9-0014
6 · The paper itself

Abstract

This study details a reliable and efficient method for CRISPR-Cas9 genome engineering in the high amino acid-producing strain of Corynebacterium glutamicum, NRRL-B11474. Our investigation demonstrates that a plasmid-encoded single-guide RNA paired with different edit-encoding fragments is sufficient to generate edits without the addition of an exogenous recombinase. This approach leverages a genome-integrated copy of the cas9 gene for reduced toxicity, in combination with a single plasmid carrying the targeting guide RNA and matching edit fragment. Our study systematically investigated the impact of homology arm length on editing efficiency and demonstrates genome editing with homology arm lengths as small as 25 bp for single-nucleotide polymorphisms and 75 bp for 100 bp sequence swaps. These homology arm lengths are smaller than previously reported for other strains of C. glutamicum. Our study finds that C. glutamicum NRRL-B11474 is not amenable to efficient transformation with plasmids containing the BL1, NG2, or CC1 origins of replication. This finding differs from all previously reported approaches to plasmid-based CRISPR-Cas9 or Cpf1 editing in other strains of C. glutamicum. Two alternative origins of replication (CG1 and CASE1) can be used to successfully introduce genome edits; furthermore, our data demonstrate improved editing efficiency when guide RNAs and edit fragments are encoded on plasmids carrying the CASE1 origin of replication (compared to plasmids carrying CG1). In addition, this study demonstrates that efficient editing can be done using an integrated Cas9 without the need for a recombinase. We demonstrate that the specifics of CRISPR-Cas9 editing configurations may need to be tailored to enable different edit types in a particular strain background. Refining configuration parameters such as edit type, homology arm length, and plasmid origin of replication enables robust, flexible, and efficient CRISPR-Cas9 editing in differing genetic strain contexts.

Indexed as

CRISPR-Cas SystemsGene EditingCorynebacterium glutamicumGene DeletionPlasmidsPolymorphism, Single NucleotideRNA, Guide, CRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsCorynebacterium glutamicumCRISPR–Cas9Genetic engineeringGenome editing

Identifiers

PMID30484125
OpenAlexW2902990575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.